BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34288245)

  • 1. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
    Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
    Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
    Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
    J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
    Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
    J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
    Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
    J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-24-1 suppresses mouse hepatoma cell invasion and metastasis via directly targeting O-GlcNAc transferase.
    Liu Y; Huang H; Liu M; Wu Q; Li W; Zhang J
    Biomed Pharmacother; 2017 Jul; 91():731-738. PubMed ID: 28499244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
    You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
    J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of OGT by microRNA24 reduces FOXA1 stability and prevents breast cancer cells invasion.
    Liu Y; Huang H; Cao Y; Wu Q; Li W; Zhang J
    Biochem Biophys Res Commun; 2017 Jun; 487(3):755-762. PubMed ID: 28455227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
    Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
    FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
    J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-23a transcriptional activated by Runx2 increases metastatic potential of mouse hepatoma cell via directly targeting Mgat3.
    Huang H; Liu Y; Yu P; Qu J; Guo Y; Li W; Wang S; Zhang J
    Sci Rep; 2018 May; 8(1):7366. PubMed ID: 29743543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability.
    Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y
    Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
    Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
    Wang L; Li G; Zhou Z; Ge C; Chen Q; Liu Y; Zhang N; Zhang K; Niu M; Li W; Zhong X; Wu S; Zhang J; Liu Y
    Oncogene; 2023 Jul; 42(30):2329-2346. PubMed ID: 37353617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.
    Korhan P; Erdal E; Kandemiş E; Cokaklı M; Nart D; Yılmaz F; Can A; Atabey N
    PLoS One; 2014; 9(8):e105278. PubMed ID: 25148256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
    Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
    Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.